Mesothelioma.com Resources for Patients and their Families
Request Free Guide

The MCA Blog

Connecting with others one story at a time Survivor Ribbon

Report Shows University of Montana Last Had Asbestos Testing in 2011

Report Shows University of Montana Last Had Asbestos Testing in 2011

Earlier this month, testing for asbestos at McGill Hall at the University of Montana raised concerns about the safety of students, particularly preschoolers who actively attended school in these classrooms. Abatement specialists found concerning levels of asbestos, well above the recommended limits set by the Environmental Protection Agency (EPA). According to law, permissible amounts of asbestos should not exceed 5,000 fibers per square centimeter. After swiping a table in one of the classrooms, which had been used and cleaned regularly, specialists found over 15,000 fibers per square centimeter. Other areas of the classrooms contained even higher concentrations of asbestos.

Continue Reading »

The 2019 International Symposium on Malignant Mesothelioma Brings Experts and Patients Together

The 2019 International Symposium on Malignant Mesothelioma Brings Experts and Patients Together

From March 25th – 27th, the Mesothelioma Applied Research Foundation will host its annual International Symposium on Malignant Mesothelioma in Bethesda, Maryland. The Meso Foundation has organized the event since 2004 to help bring the mesothelioma community together, offering patients and loved ones insight to the latest treatments and research, facetime with renowned mesothelioma experts, and the opportunity to connect with others facing similar experiences.

Continue Reading »

Two Clinical Trials Show Potential of Opdivo for Recurrent Mesothelioma

Two Clinical Trials Show Potential of Opdivo for Recurrent Mesothelioma

One of the prominent areas of mesothelioma research today is around the development of an effective, tolerable, second-line treatment for recurrent cases. Studies have shown mesothelioma recurrence is highly prevalent, even among patients who are able to undergo aggressive primary therapy, like surgery. Some studies have noted recurrence rates ranging from 10 – 72% of patients.

Continue Reading »

Preschoolers Exposed to Dangerous Amounts of Asbestos at the University of Montana

Preschoolers Exposed to Dangerous Amounts of Asbestos at the University of Montana

Asbestos in schools has been a long-standing concern. In 2015, there were 131,000 public and private schools running in the United States, and one-third of them were thought to have contained asbestos. Everything from ceiling tiles to insulation and heating ducts has caused asbestos exposure in schools, putting both teachers and students at risk of developing asbestos diseases like mesothelioma.

Continue Reading »

Lucky 13: Celebrating 13 Years of Survivorship

Lucky 13: Celebrating 13 Years of Survivorship | Mesothelioma.com

February 2nd, 2019 will mark 13 years since my life-saving surgery done by the late Dr. David Sugarbaker. 13 years was not even something I thought I could achieve all those years ago when I was told I had just 15 months to live. Over the last 13 years, I have had so much to be thankful and grateful for. All I have to do is look at my daughter, who was just a tiny, serious baby when I was diagnosed, and now she is taller than I am – a fact she is all too happy to point out at every moment possible! 13 years of scanxiety, 13 years of advocacy, and 13 years of living for today.

Continue Reading »

Resources for Mesothelioma Patients and Their Families

Immunotherapy Drug Avelumab Could Extend Survival for Patients with Unresectable Mesothelioma

Immunotherapy Drug Avelumab Could Extend Survival for Patients with Unresectable Mesothelioma

An early-phase clinical trial through the National Cancer Institute found promising results for a new immunotherapy drug, avelumab, in the treatment of unresectable pleural mesothelioma. The study tested the safety and efficacy of the drug on 53 mesothelioma patients who had previously been treated with chemotherapy and seen disease progression.

Continue Reading »

How Dropping DNA into Water May Reveal Mesothelioma

How Dropping DNA into Water May Reveal Mesothelioma

Scientists at the University of Queensland in Australia have been working to find a cancer test that will detect cancer sooner, allowing patients to begin treatment earlier and improve their prognosis. This is particularly influential for rare cancers like malignant mesothelioma that are difficult to detect. Early detection is the best way to improve mesothelioma prognosis, stressing the need to find better diagnostic tools.

Continue Reading »

Dealing With a Cancer Diagnosis or Treatment During the Holidays

Dealing With a Cancer Diagnosis or Treatment During the Holidays

The holidays can be magical and stressful, make you thankful or hate everything. But when you add in a cancer diagnosis, treatment, or a hospital stay, or any illness to the season, you end up dealing with so much more. The season comes with some pretty high expectations and along with that, equal disappointment. I learned LONG ago to tamper expectations and try not to get carried away, but it isn’t always that easy.

Continue Reading »

Study Finds Radiation Before Surgery Can Make Immunotherapy More Effective for Mesothelioma

Study Finds Radiation Before Surgery Can Make Immunotherapy More Effective for Mesothelioma

Mesothelioma is often treated with a multimodal therapy of surgery, chemotherapy, and radiation therapy. Though these treatments are considered the standards of care, as curative and palliative options, researchers have debated the exact role of radiation for mesothelioma over the years. Some studies have suggested the therapy is not effective and mesothelioma tumors may be resistant to the treatment overall. Others have claimed that the treatment is best used palliatively to shrink tumors and help alleviate symptoms.

Continue Reading »

DREAM Study Results Offer Hope for Mesothelioma Patients

DREAM Study Results Offer Hope for Mesothelioma Patients

Researchers of a phase 2 clinical trial for malignant pleural mesothelioma testing immunotherapy drug durvalumab with the standard first-line chemotherapy treatment, pemetrexed and cisplatin, have seen encouraging results that suggest the new combination could be a treatment option for patients.

Continue Reading »

< Previous Next >

Search the MCA Blog:

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide